News
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
6h
TipRanks on MSNNovo Nordisk’s Stock Soars Amid Strategic Moves
Novo Nordisk ( ($NVO) ) has risen by 10.44%. Read on to learn why. Novo Nordisk has seen a notable 10.44% increase in its stock price over the ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.
More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
An NHS surgeon has delivered his 'hot take' on why weight-loss jabs like Wegovy and Mounjaro are causing 'Ozempic babies' to be born.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results